| PDB Identifier | Description | Ligand | Receptor | SCOP | pdb.org | |
|---|---|---|---|---|---|---|
![]() |
2V3O | THROMBIN WITH 3-CYCLE WITH F | I | H |
|
|
![]() |
2ZC9 | Thrombin in complex with Inhibitor | L | H |
|
|
![]() |
2ZGB | Thrombin Inhibition | L | H |
|
|
![]() |
2ZGX | Thrombin Inhibition | L | H |
|
|
![]() |
2ZHE | Exploring thrombin S3 pocket | L | H |
|
|
![]() |
2ZHF | Exploring thrombin S3 pocket | L | H |
|
|
![]() |
2ZHQ | Thrombin Inhibition | L | H |
|
|
![]() |
2ZHW | Exploring thrombin S3 pocket | L | H |
|
|
![]() |
2ZI2 | Thrombin Inhibition | L | H |
|
|
![]() |
2ZIQ | Thrombin Inhibition | L | H |
|
|
![]() |
2ZNK | Thrombin Inhibition | L | H |
|
|
![]() |
2ZO3 | Bisphenylic Thrombin Inhibitors | L | H |
|
|
![]() |
3C27 | Cyanofluorophenylacetamides as Orally Efficacious Thrombin Inhibitors | H | B |
|
|
![]() |
3C59 | Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain | B | A |
|
|
![]() |
3C5T | Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain | B | A |
|
|
![]() |
3D49 | Thrombin Inhibition | L | H |
|
|
![]() |
3DA9 | Crystal structure of thrombin in complex with inhibitor | A | B |
|
|
![]() |
3DDA | Crystal structure of the catalytic domain of Botulinum neurotoxin serotype a with a snap-25 peptide | B | A |
|
|
![]() |
3DDB | Crystal structure of the catalytic domain of Botulinum neurotoxin serotype a with a substrate analog peptide | B | A |
|
|
![]() |
3DHK | Bisphenylic Thrombin Inhibitors | L | H |
|
|
![]() |
3DT0 | Understanding Thrombin Inhibition | L | H |
|
|
![]() |
3DUX | Understanding Thrombin Inhibition | L | H |
|
|
![]() |
3EGK | KNOBLE Inhibitor | L | H |
|
|
![]() |
3FP7 | Anionic trypsin variant S195A in complex with bovine pancreatic trypsin inhibitor (BPTI) cleaved at the scissile bond (LYS15-ALA16) determined to the 1.46 A resolution limit | I | JE |
|
|
![]() |
3GIC | Structure of thrombin mutant delta(146-149e) in the free form | A | B |
|